Mode
Text Size
Log in / Sign up

Statistical Analysis Plan Defines ICD Insertion Based on Ventricular Scar for Left Ventricular Systolic Dysfunction

Statistical Analysis Plan Defines ICD Insertion Based on Ventricular Scar for Left Ventricular Systo…
Photo by Navy Medicine / Unsplash
Key Takeaway
Note this document is a statistical analysis plan pre-specifying methods without reporting trial results or outcomes.

This publication is a statistical analysis plan rather than a report of clinical trial results. It outlines the pre-specified methods for analyzing data from a study involving patients with mild moderate left ventricular systolic dysfunction. The document details the planned statistical approach for evaluating the insertion of an Implantable Cardioverter Defibrillator based on the presence of ventricular scar or fibrosis.

The primary outcome is defined as a composite of sudden cardiac death or haemodynamically significant ventricular arrhythmia. This arrhythmia is specified as producing syncope or associated with hypotension (SBP<90mmHg) except directly associated with device implant procedure. Standard care serves as the comparator for this planned analysis.

Crucially, this document does not contain any reported outcomes, effect sizes, or statistical significance values. The sample size, follow-up duration, and setting are not reported within this text. Because this is a protocol for analysis, no safety data, adverse events, or discontinuations are presented here.

Clinicians should recognize that this text establishes the framework for future data interpretation rather than providing evidence of efficacy or safety. The absence of results means no conclusions regarding the benefit of the intervention can be drawn from this document alone. Further reporting of the trial results will be necessary to determine clinical relevance.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
The CMR Guide trial aims to determine whether the insertion of an Implantable Cardioverter Defibrillator based on the presence of ventricular scar/fibrosis will reduce sudden cardiac death or syncopal ventricular arrhythmia in patients with mild moderate left ventricle systolic dysfunction compared to standard care. This statistical analysis plan pre-specifies the method of analysis for every outcome and key variables collected in the trial. The primary outcome is a composite of sudden cardiac death or haemodynamically significant ventricular arrhythmia defined as ventricular arrhythmia producing syncope (loss of consciousness) or associated with hypotension (SBP<90mmHg) except directly associated with device implant procedure. The main analysis will consist of a Fine and Gray survival model of time to first occurrence of a primary outcome treating deaths other than sudden cardiac deaths as competing risks. The analysis plan also includes planned sensitivity analyses including covariate adjustments and subgroup analyses.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.